Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?
Join us for this engaging debate on the future of acquired TTP (aTTP) treatment chaired by Dr. Eleni Gavriilaki from Aristotle University of Thessaloniki in Greece. This discussion features Prof. Marie Scully from University College London Hospital in UK and Prof. Paul Coppo from Saint-Antoine Hospital in Paris, France. The debate centers on whether therapeutic plasma exchange (PEX) combined with immunosuppression, long considered the standard treatment for acute aTTP episodes, has become obsolete with the advent of new therapies.
First Prof. Scully argues that plasmapheresis is indeed a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.